相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Efficacy and Safety of Dupilumab in Adolescents With Uncontrolled Moderate to Severe Atopic Dermatitis A Phase 3 Randomized Clinical Trial
Eric L. Simpson et al.
JAMA DERMATOLOGY (2020)
Efficacy of Dupilumab in a Phase 2 Randomized Trial of Adults With Active Eosinophilic Esophagitis
Ikuo Hirano et al.
GASTROENTEROLOGY (2020)
Efficacy of Dupilumab for Controlling Severe Atopic Dermatitis in a Patient with Hyper-IgE Syndrome
Romain Levy et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2020)
Dupilumab to treat severe atopic dermatitis in autosomal dominant hyper-IgE syndrome
Georgios Sogkas et al.
CLINICAL IMMUNOLOGY (2020)
Gastrointestinal Manifestations of STAT3-Deficient Hyper-IgE Syndrome
Manish Arora et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2017)
Diagnostic approach to the hyper-IgE syndromes: Immunologic and clinical key findings to differentiate hyper-IgE syndromes from atopic dermatitis
Lena F. Schimke et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)
Novel signal transducer and activator of transcription 3 (STAT3) mutations, reduced TH17 cell numbers, and variably defective STAT3 phosphorylation in hyper-IgE syndrome
Ellen D. Renner et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2008)
分享论文
